These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Review of low-grade gliomas in children--evolving molecular era and therapeutic insights. Khatua S; Wang J; Rajaram V Childs Nerv Syst; 2015 May; 31(5):643-52. PubMed ID: 25722047 [TBL] [Abstract][Full Text] [Related]
36. Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition. O'Hare P; Cooney T; de Blank P; Gutmann DH; Kieran M; Milde T; Fangusaro J; Fisher M; Avula S; Packer R; Fukuoka K; Mankad K; Mueller S; Waanders AJ; Opocher E; Bouffet E; Raabe E; Werle NE; Azizi AA; Robison NJ; Hernáiz Driever P; Russo M; Schouten N; van Tilburg CM; Sehested A; Grill J; Bandopadhayay P; Kilday JP; Witt O; Ashley DM; Ertl-Wagner BB; Tabori U; Hargrave DR Neuro Oncol; 2024 Aug; 26(8):1357-1366. PubMed ID: 38743009 [TBL] [Abstract][Full Text] [Related]
37. Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas. Fernández MB; Alonso VP Childs Nerv Syst; 2016 Oct; 32(10):1939-45. PubMed ID: 27659836 [TBL] [Abstract][Full Text] [Related]